Frank Verwiel, M.D., President and Chief Executive Officer, of Axcan Pharma Inc.,
Rings The NASDAQ Stock Market Closing Bell

Tuesday, December 12, 2006
at NASDAQ's MarketSite
in New York City.

Axcan Pharma Inc.
[AXCA]

Frank Verwiel, M.D., President and Chief Executive Officer, of Axcan Pharma Inc. (AXCA) and members of the Axcan management team. preside over the closing bell. Axcan began trading on NASDAQ in 2000.
Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 12/12/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Frank Verwiel, M.D., President and Chief Executive Officer, of Axcan Pharma Inc., Rings The NASDAQ Stock Market Closing Bell. These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.